Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Differentially Methylated Regions Identified by Genome-Wide DNA Methylation Analyses Contribute to Racial Disparities in Childhood Obesity. | Genes (Basel) | 2023 | 37239458 | PubTator, text mining | PubMed |
| Evolving Diagnostic and Treatment Strategies for Pediatric CNS Tumors: The Impact of Lipid Metabolism. | Biomedicines | 2023 | 37239036 | PubTator, text mining | PubMed |
| Neural induction drives body axis formation during embryogenesis, but a neural induction-like process drives tumorigenesis in postnatal animals. | Front Cell Dev Biol | 2023 | 37228646 | PubTator, text mining | PubMed |
| Mass spectrometry-based phosphoproteomics in clinical applications. | Trends Analyt Chem | 2023 | 37215489 | PubTator, text mining | PubMed |
| Role of Mesenchymal Stem Cells on Tonsillar Hypertrophy: An Unexplored Enigma. | JNMA J Nepal Med Assoc | 2023 | 37203931 | PubTator, text mining | PubMed |
| Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway in vivo and in vitro. | J Gastrointest Oncol | 2023 | 37201092 | PubTator, text mining | PubMed |
| Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases. | Cancers (Basel) | 2023 | 37190200 | PubTator, text mining | PubMed |
| Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data. | Biomolecules | 2023 | 37189432 | PubTator, text mining | PubMed |
| Fibrates Affect Levels of Phosphorylated p38 in Intestinal Cells in a Differentiation-Dependent Manner. | Int J Mol Sci | 2023 | 37175404 | PubTator, text mining | PubMed |
| Specificity models in MAPK cascade signaling. | FEBS Open Bio | 2023 | 37157227 | PubTator, text mining | PubMed |
The mTOR inhibitor rapamycin suppresses trigeminal neuropathic pain and p-MKK4/p-p38 mitogen-activated protein kinase-mediated microglial activation in the trigeminal nucleus caudalis of mice with infraorbital nerve injury. | Front Mol Neurosci | 2023 | 37122619 | PubTator, text mining | PubMed |
| Combination of CNP, MT and FLI during IVM Significantly Improved the Quality and Development Abilities of Bovine Oocytes and IVF-Derived Embryos. | Antioxidants (Basel) | 2023 | 37107273 | PubTator, text mining | PubMed |
| The Blockade of Mitogen-Activated Protein Kinase 14 Activation by Marine Natural Product Crassolide Triggers ICD in Tumor Cells and Stimulates Anti-Tumor Immunity. | Mar Drugs | 2023 | 37103364 | PubTator, text mining | PubMed |
| Bladder cancer organoids as a functional system to model different disease stages and therapy response. | Nat Commun | 2023 | 37072390 | PubTator, text mining | PubMed |
| ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin. | Proc Natl Acad Sci U S A | 2023 | 37068230 | PubTator, text mining | PubMed |
| Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer. | Front Oncol | 2023 | 37064116 | PubTator, text mining | PubMed |
| KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma. | Cancers (Basel) | 2023 | 37046732 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets. | Clin Proteomics | 2023 | 37031178 | PubTator, text mining | PubMed |
| Identification of a peptide ligand for human ALDH3A1 through peptide phage display: Prediction and characterization of protein interaction sites and inhibition of ALDH3A1 enzymatic activity. | Front Mol Biosci | 2023 | 37021113 | PubTator, text mining | PubMed |
| A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome. | PLoS One | 2023 | 37018234 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=10